344 related articles for article (PubMed ID: 21980514)
1. Dopamine-induced plasticity, phospholipase D (PLD) activity and cocaine-cue behavior depend on PLD-linked metabotropic glutamate receptors in amygdala.
Krishnan B; Genzer KM; Pollandt SW; Liu J; Gallagher JP; Shinnick-Gallagher P
PLoS One; 2011; 6(9):e25639. PubMed ID: 21980514
[TBL] [Abstract][Full Text] [Related]
2. Cocaine withdrawal reduces group I mGluR-mediated long-term potentiation via decreased GABAergic transmission in the amygdala.
Schmidt K; Krishnan B; Xia Y; Sun A; Orozco-Cabal L; Pollandt S; Centeno M; Genzer K; Gallagher JP; Shinnick-Gallagher P; Liu J
Eur J Neurosci; 2011 Jul; 34(2):177-89. PubMed ID: 21749491
[TBL] [Abstract][Full Text] [Related]
3. Fear potentiated startle increases phospholipase D (PLD) expression/activity and PLD-linked metabotropic glutamate receptor mediated post-tetanic potentiation in rat amygdala.
Krishnan B; Scott MT; Pollandt S; Schroeder B; Kurosky A; Shinnick-Gallagher P
Neurobiol Learn Mem; 2016 Feb; 128():65-79. PubMed ID: 26748024
[TBL] [Abstract][Full Text] [Related]
4. Cocaine and kindling alter the sensitivity of group II and III metabotropic glutamate receptors in the central amygdala.
Neugebauer V; Zinebi F; Russell R; Gallagher JP; Shinnick-Gallagher P
J Neurophysiol; 2000 Aug; 84(2):759-70. PubMed ID: 10938303
[TBL] [Abstract][Full Text] [Related]
5. Bidirectional regulation of synaptic plasticity in the basolateral amygdala induced by the D1-like family of dopamine receptors and group II metabotropic glutamate receptors.
Li C; Rainnie DG
J Physiol; 2014 Oct; 592(19):4329-51. PubMed ID: 25107924
[TBL] [Abstract][Full Text] [Related]
6. Metabotropic glutamate receptor I (mGluR1) antagonism impairs cocaine-induced conditioned place preference via inhibition of protein synthesis.
Yu F; Zhong P; Liu X; Sun D; Gao HQ; Liu QS
Neuropsychopharmacology; 2013 Jun; 38(7):1308-21. PubMed ID: 23348064
[TBL] [Abstract][Full Text] [Related]
7. Dopamine receptor mechanisms mediate corticotropin-releasing factor-induced long-term potentiation in the rat amygdala following cocaine withdrawal.
Krishnan B; Centeno M; Pollandt S; Fu Y; Genzer K; Liu J; Gallagher JP; Shinnick-Gallagher P
Eur J Neurosci; 2010 Mar; 31(6):1027-42. PubMed ID: 20377617
[TBL] [Abstract][Full Text] [Related]
8. Long-term depression induced by postsynaptic group II metabotropic glutamate receptors linked to phospholipase C and intracellular calcium rises in rat prefrontal cortex.
Otani S; Daniel H; Takita M; Crépel F
J Neurosci; 2002 May; 22(9):3434-44. PubMed ID: 11978820
[TBL] [Abstract][Full Text] [Related]
9. Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior.
See RE; Kruzich PJ; Grimm JW
Psychopharmacology (Berl); 2001 Mar; 154(3):301-10. PubMed ID: 11351937
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D1 or D2 receptor antagonism within the basolateral amygdala differentially alters the acquisition of cocaine-cue associations necessary for cue-induced reinstatement of cocaine-seeking.
Berglind WJ; Case JM; Parker MP; Fuchs RA; See RE
Neuroscience; 2006; 137(2):699-706. PubMed ID: 16289883
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D1/D5 receptors in the dorsal hippocampus are required for the acquisition and expression of a single trial cocaine-associated memory.
Kramar CP; Barbano MF; Medina JH
Neurobiol Learn Mem; 2014 Dec; 116():172-80. PubMed ID: 25452086
[TBL] [Abstract][Full Text] [Related]
12. Dissociable effects of cocaine-seeking behavior following D1 receptor activation and blockade within the caudal and rostral basolateral amygdala in rats.
Mashhoon Y; Tsikitas LA; Kantak KM
Eur J Neurosci; 2009 Apr; 29(8):1641-53. PubMed ID: 19419427
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional synaptic plasticity in the rat basolateral amygdala: characterization of an activity-dependent switch sensitive to the presynaptic metabotropic glutamate receptor antagonist 2S-alpha-ethylglutamic acid.
Li H; Weiss SR; Chuang DM; Post RM; Rogawski MA
J Neurosci; 1998 Mar; 18(5):1662-70. PubMed ID: 9464991
[TBL] [Abstract][Full Text] [Related]
14. Synergistic activation of dopamine D1 and TrkB receptors mediate gain control of synaptic plasticity in the basolateral amygdala.
Li C; Dabrowska J; Hazra R; Rainnie DG
PLoS One; 2011; 6(10):e26065. PubMed ID: 22022509
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of group I metabotropic glutamate receptor mediated LTP and LTD in basolateral amygdala in vitro.
Chen A; Hu WW; Jiang XL; Potegal M; Li H
Psychopharmacology (Berl); 2017 Feb; 234(4):681-694. PubMed ID: 28028604
[TBL] [Abstract][Full Text] [Related]
16. D1/D5 Dopamine Receptors and mGluR5 Jointly Enable Non-Hebbian Long-Term Potentiation at Sensory Synapses onto Lamina I Spinoparabrachial Neurons.
Li J; Price TJ; Baccei ML
J Neurosci; 2022 Jan; 42(3):350-361. PubMed ID: 34815314
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of metabotropic glutamate receptor antagonists on bursting activity in the amygdala.
Keele NB; Neugebauer V; Shinnick-Gallagher P
J Neurophysiol; 1999 May; 81(5):2056-65. PubMed ID: 10322047
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of metabotropic glutamate receptors coupled to phospholipase D in the rat hippocampus.
Pellegrini-Giampietro DE; Torregrossa SA; Moroni F
Br J Pharmacol; 1996 Jun; 118(4):1035-43. PubMed ID: 8799579
[TBL] [Abstract][Full Text] [Related]
19. Chronic morphine treatment switches the effect of dopamine on excitatory synaptic transmission from inhibition to excitation in pyramidal cells of the basolateral amygdala.
Li Z; Luan W; Chen Y; Chen M; Dong Y; Lai B; Ma L; Zheng P
J Neurosci; 2011 Nov; 31(48):17527-36. PubMed ID: 22131414
[TBL] [Abstract][Full Text] [Related]
20. Antagonist pharmacology of metabotropic glutamate receptors coupled to phospholipase D activation in adult rat hippocampus: focus on (2R,1'S,2'R,3'S)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine versus 3, 5-dihydroxyphenylglycine.
Albani-Torregrossa S; Attucci S; Marinozzi M; Pellicciari R; Moroni F; Pellegrini-Giampietro DE
Mol Pharmacol; 1999 Apr; 55(4):699-707. PubMed ID: 10101028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
